MedTrace Logo

Weight Fluctuation After Breast Cancer Treatment

NCT00991653 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2018-09-07

No results posted yet for this study

Summary

This study aims to identify and quantify the factors associated with excess weight gain following treatment for breast cancer. It is believed that breast cancer patients gain more than 4% of their weight at diagnosis which is likely accompanied by an increase in body fat and waist circumference. It is further thought that this excess weight and increase in body fat and waist circumference are associated to tumour characteristics, chemotherapy, menopause status at diagnosis and the presence of genes related to obesity. It is also thought that women treated with chemotherapy have higher levels of glucose and insulin.

Conditions

Interventions

PROCEDURE

Fasting blood sample.

Fasting blood sample taken following informed consent for genotyping, glucose and insulin levels.

Sponsors & Collaborators

  • The Royal Bournemouth Hospital

    lead OTHER

Principal Investigators

  • Tamas Hickish · Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2013-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00991653 on ClinicalTrials.gov